Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKesson
Chubb
Colorcon
Baxter
UBS
Accenture
Harvard Business School
Dow
Healthtrust
Daiichi Sankyo

Generated: February 19, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 050285

« Back to Dashboard

NDA 050285 describes MYCIFRADIN, which is a drug marketed by Pharmacia And Upjohn and is included in two NDAs. Additional details are available on the MYCIFRADIN profile page.

The generic ingredient in MYCIFRADIN is neomycin sulfate. There are nineteen drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the neomycin sulfate profile page.
Summary for 050285
Tradename:MYCIFRADIN
Applicant:Pharmacia And Upjohn
Ingredient:neomycin sulfate
Patents:0
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 050285

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:SOLUTION;ORALStrengthEQ 87.5MG BASE/5ML
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Fish and Richardson
Deloitte
US Army
Covington
Argus Health
Medtronic
Baxter
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot